Concepedia

Liraz Shmuel-Galia

LS

Statistics

Publications

9

Citations

1.3K

H-Index

9

Active since

2012

Affiliations

University of Massachusetts Chan Medical School(Current)

GlaxoSmithKline (United States)

Weizmann Institute of Science

Liraz Shmuel-Galia is an author at University of Massachusetts Chan Medical School specializing in life sciences, inflammation, and innate immunity.

ORCID

Publications per year

2012–2024

9

Publications

9

Succination inactivates gasdermin D and blocks pyroptosis

Fiachra Humphries, Liraz Shmuel-Galia, Natália Ketelut-Carneiro et al. · Science · 2020 · 655 citations · Full text

, , +17

A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection

Fiachra Humphries, Liraz Shmuel-Galia, Zhaozhao Jiang et al. · Science Immunology · 2021 · 168 citations · Full text

, , +6

D-Alanylation of Lipoteichoic Acids Confers Resistance to Cationic Peptides in Group B Streptococcus by Increasing the Cell Wall Density

Ron Saar-Dover, Arkadi Bitler, Ravit Nezer et al. · PLoS Pathogens · 2012 · 167 citations · Full text

, , +17

Dysbiosis exacerbates colitis by promoting ubiquitination and accumulation of the innate immune adaptor STING in myeloid cells

Liraz Shmuel-Galia, Fiachra Humphries, Xuqiu Lei et al. · Immunity · 2021 · 141 citations · Full text

, , +16

Targeting STING oligomerization with small-molecule inhibitors

Fiachra Humphries, Liraz Shmuel-Galia, Zhaozhao Jiang et al. · Proceedings of the National Academy of Sciences · 2023 · 72 citations · Full text

, , +17

1–5 of 9